Related Experiment Video
Updated: Jun 13, 2026

Saccharomyces cerevisiae Models of Alzheimer's Disease to Screen Genes, Mutations, and Chemicals Affecting Amyloid Beta Production by γ-Secretase
Published on: June 24, 2025
[New mutation in the PSEN1 (E120G) gene associated with early onset Alzheimer's disease]
A Lladó1, R Sánchez-Valle, M J Rey
1Unitat d'Alzheimer i altres trastorns cognitius, Servei de Neurologia, ICN, Hospital Clínic de Barcelona, Institut d'Investigació Biomédica August Pi i Sunyer (IDIBAPS), Barcelona, España. allado@clinic.ub.es
Objective:
To describe a novel mutation in exon 5 of the presenilin 1 gene (E120G)associated with early-onset autosomal dominant Alzheimer's disease (AD).
Patient And Methods:
The proband was a man who began with memory loss and progressive cognitive decline at the age of 34. His father and his sister suffered from early-onset cognitive decline. The genetic study performed on the blood sample using the single strand conformation polymorphism (SSCP) technique did not detect any abnormality suggestive of the presence of a mutation in PSEN1, PSEN2, and APP. In the last stage of the disease the patient had seizures and gait alteration. He died at the age of 44. Coding exons 3-12 of PSEN1 were studied by direct sequencing using isolated DNA from frozen brain tissue of the proband.
Results:
The neuropathological examination showed the presence of frequent amyloid plaques and neurofibrillary tangles and severe amyloid angiopathy. The direct sequencing of the PSEN1 gene disclosed the presence of the E120G mutation.
Conclusions:
E120G is a novel mutation in PSEN1 that probably causes early-onset autosomal dominant AD. Absence of genetic alterations in screening techniques (SSCP) does not rule out the presence of mutations. We recommend direct sequencing for the genetic study of patients with early-onset autosomal dominant AD.
Related Concept Videos
Alzheimer Disease l: Introduction
Parkinson Disease ll: Pathophysiology
Alzheimer Disease ll: Pathophysiology
Neural Regulation
Parkinson Disease l: Introduction
Alzheimer's Disease: Overview
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ and tau...
